Tabersonine

CAS No. 4429-63-4

Tabersonine( (–)-Tabersonine )

Catalog No. M14511 CAS No. 4429-63-4

Tabersonineis a terpene indole alkaloid found in the medicinal plantCatharanthus roseus.

Tabersonineis a terpene indole alkaloid found in the medicinal plantCatharanthus roseus.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 69 In Stock
10MG 97 In Stock
25MG 161 In Stock
50MG 239 In Stock
100MG 356 In Stock
500MG 844 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tabersonine
  • Note
    Research use only, not for human use.
  • Brief Description
    Tabersonineis a terpene indole alkaloid found in the medicinal plantCatharanthus roseus.
  • Description
    Tabersonineis a terpene indole alkaloid found in the medicinal plantCatharanthus roseus.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (–)-Tabersonine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    4429-63-4
  • Formula Weight
    336.43
  • Molecular Formula
    C21H24N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in Chloroform
  • SMILES
    CC[C@]1(C=CC(N2CC[C@@]34[C@@]21[H])=O)CC(C(OC)=O)=C4NC5=C3C=CC(OC)=C5
  • Chemical Name
    Methyl (5alpha,19alpha)-16-methoxy-8-oxo-2,3,6,7-tetradehydroaspidospermidine-3-carboxylate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • N-Sulfo-glucosamine ...

    N-Sulfo-glucosamine sodium salt is possible to effect reaction at arthritis.

  • Fibrinogen Binding I...

    Fibrinogen Binding Inhibitor Peptide, a synthetic dodecapeptide, represents the specific platelet receptor recognition site of the human fibrinogen g-chain (residues 400-411).

  • TAS-102

    TAS-102 is an investigational drug candidate for metastatic colorectal Y. It contains trifluridine (TFT) and Tipiracil hydrochloride (TTP) in a molar ratio of 2:1.